In 2021, the FDA warned doctors about potential inaccuracies with oximeters after a study found the devices tended to overestimate Black patients’ oxygen levels, which could lead to delays in ...

Problems with pulse oximeters have been known for decades, but it wasn’t until the pandemic that the real dangers to Black patients became clear.

Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Problems with pulse oximeters have been known for decades, but it wasn’t until the pandemic that the real dangers to Black patients became clear.

The global pulse oximeters market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to ...

For decades, widely used pulse oximeters have underestimated the oxygen needs of darker-skinned patients. Will the FDA's new guidelines fix that?

FDA recommends fixing racial disparities in pulse oximeter readings Inaccurate readings in the medical devices led to inferior care for Black patients.

Pulse oximeters intended for use in medical decision making or monitoring, whether at home or in a clinical setting, go through this FDA pathway.

Problems with pulse oximeters have been known for decades, but it wasn’t until the pandemic that the real dangers to Black patients became clear.

Federal health officials are proposing changes to make sure medical devices that measure oxygen levels are working for patients of color.